Pharma
sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Most Viewed Abstracts



Your Article Summary

See Latest Articles
(Click the title below to leave the MDLinx Network and go to the Journal's Website)

President Clinton and Mylan Chairman and CEO Robert J. Coury Announce New Agreement to Lower Price of Treatment for Patients with Drug-Resistant HIV in Developing Countries
Mylan, 08/07/09

President Bill Clinton, Mylan Chairman and CEO Robert J. Coury and Matrix Laboratories Founder and Vice Chairman N. Prasad today announced an important agreement to enable better, more affordable treatments for patients on "second–line" antiretroviral (ARV) therapy for HIV/AIDS in the developing world. For the first time, a second–line regimen of four ARVs will be available for under $500 annually.

Today in M&A/Partnerships...keeping you current

Bayer CropScience and FuturaGene sign license agreement for drought tolerance technology in cotton
BayNews International, 12/04/09

Sanofi-aventis enters into an Exclusive Global Licensing Agreement with The Rockefeller University
Sanofi-aventis, 12/04/09

Watson Receives FTC Clearance for Arrow Acquisition
Watson Pharmaceuticals, 12/03/09

 See all of M&A/Partnerships

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Send this Summary to a Colleague

Enter email address